RhumbLine Advisers’s Molecular Partners MOLN Stock Holding History

RhumbLine Advisers’s Portfolio MOLN Stock Details MOLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-269	Closed	-$1.09K	–	4214
2025 Q1	$1.09K	Hold	269	–	–	﹤0.01%	4026
2024 Q4	$1.28K	Hold	269	–	–	﹤0.01%	4060
2024 Q3	$1.3K	Hold	269	–	–	﹤0.01%	4082
2024 Q2	$1.92K	Hold	269	–	–	﹤0.01%	4190
2024 Q1	$1.04K	Hold	269	–	–	﹤0.01%	4143
2023 Q4	$1.07K	Hold	269	–	–	﹤0.01%	4148
2023 Q3	$1.07K	Hold	269	–	–	﹤0.01%	4175
2023 Q2	$1.64K	Buy	+269	New	+$1.75K	﹤0.01%	4240

Other funds holding MOLN

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $3.28B AUM 23.66% 1-Year Est. Return

RhumbLine Advisers's MOLN Position: Q2 2025 in Review

RhumbLine Advisers sold out of Molecular Partners (MOLN) in Q2 2025, closing a stake of 269 shares — an estimated $1.09K sold.

RhumbLine Advisers first reported a position in MOLN in Q2 2023 and held it in 8 quarters. The position peaked at $1.92K in Q2 2024. 6 funds tracked by Wall St. Rank hold MOLN as of Q2 2025.

RhumbLine Advisers reported no remaining Molecular Partners position as of Q2 2025 after selling out during the quarter.
RhumbLine Advisers sold 269 Molecular Partners shares in Q2 2025, an estimated $1.09K.
RhumbLine Advisers first reported a position in Molecular Partners in Q2 2023 and held it in 8 quarters.
RhumbLine Advisers's Molecular Partners position peaked at $1.92K in Q2 2024.
6 funds tracked by Wall St. Rank held Molecular Partners as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.